IVDR: where are we now in molecular testing? How IVDR implementation is progressing in molecular biology laboratories in different European countries IVDR, the new EU legislation for in-vitro ...

cobas 5800 is a new compact addition to the Roche molecular diagnostics portfolio that provides a scalable, high performance testing solution for labs of all sizes. Infectious diseases, such as HIV, ...

Researchers at the University of Pennsylvania have developed ApexGO, a novel, AI-powered method for turning promising but ...

Please provide your email address to receive an email when new articles are posted on . Precision medicine has shown great potential to improve treatment outcomes and prolong survival of patients with ...

Join us for an insightful webinar on the critical role of molecular diagnostic testing for respiratory viruses during flu season. This session will explore the importance of accurate and timely ...

ARUP Laboratories announced today the launch of its National Infectious Disease Test Positivity Trends Dashboard, the first ...

Earnings Call Insights: Insight Molecular Diagnostics Inc. (IMDX) Q3 2025 CEO Joshua Riggs highlighted that Insight Molecular Diagnostics is nearing a transformative milestone, stating, "In 2026, with ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The company, which helps ...

Insight Molecular Diagnostics Inc (IMDX) showcases international expansion and regulatory progress, while navigating financial hurdles and market uncertainties.

According to MarketsandMarkets, the Molecular Infectious Disease Testing Market is projected to grow from about USD 11.30 billion in 2026 to ...